Glycopyrronium bromide neostigmine injection split charging structure

Abstract

The utility model relates to the technical field of split charging equipment, in particular to a glycopyrronium bromide neostigmine injection split charging structure which comprises a split charging table, a plurality of openings are evenly formed in the top of the split charging table, a second air cylinder is arranged in each opening, a conical block is arranged at the output end of each second air cylinder, and a plurality of second sliding rods are evenly connected to the outer side of each conical block in a sliding mode. The other end of the second sliding rod is fixedly connected to the outer side of the bottom end of a clamping rod, a rotating shaft is arranged in the middle of the clamping rod, and fixing plates are arranged at the two ends of the rotating shaft. The second air cylinder is started to drive the conical block at the output end of the second air cylinder to move, when the conical block moves, the second sliding rod matched with the conical block can be driven to move by means of the shape of the conical block, and the clamping rod connected with the second sliding rod can be driven to rotate with the rotating shaft as the center through movement of the second sliding rod. When the clamping rod rotates, the first sliding rod moves in the sliding groove to play a guiding role, and the injection bottle at the top of the base plate is clamped through rotation of the clamping rod.

Description

Technical Field

[0001] This utility model relates to the field of dispensing equipment technology, and in particular to a dispensing structure for neostigmine glycopyrronium bromide injection. Background Technology

[0002] Neostigmine is a quaternary ammonium cholinesterase inhibitor that exerts its cholinergic effect by inhibiting cholinesterase activity. It is primarily used for its skeletal muscle effects in myasthenia gravis and to antagonize neuromuscular blockade during anesthesia. However, it can also cause adverse reactions such as muscarinic cholinergic receptor excitation, including junctional escape rhythm, complete atrioventricular block, and even cardiac arrest.

[0003] Glycerone bromide, a quaternary ammonium anticholinergic drug, antagonizes muscarinic symptoms induced by neostigmine. The combined use of these two drugs reduces initial tachycardia while maintaining the muscle relaxant antagonistic effect, and also provides better protection against the subsequent cholinergic effects of neostigmine. Therefore, the combination of glycopyrronium bromide and neostigmine provides stronger cardiac stability than neostigmine alone. Furthermore, due to the limited penetration of glycopyrronium bromide into the central nervous system, residual central anticholinergic effects are minimized. Glycerone bromide-neostigmine injection is suitable for reversing residual non-depolarizing (competitive) neuromuscular blockade.

[0004] In existing technologies, injection bottles of different sizes are dispensed according to different process requirements. However, most filling equipment is of fixed size and lacks a fixing device. Usually, the injection bottle is placed directly under the injection port for filling. During the filling process, the injection bottle will be tilted due to the impact of the injection liquid. The splashed injection liquid will not only affect the equipment, but also reduce the dispensing efficiency. Utility Model Content

[0005] This utility model addresses the shortcomings of existing technologies by providing the following technical solution:

[0006] A dispensing structure for neostigmine bromide injection includes a dispensing platform. The top of the dispensing platform has several openings evenly distributed. A second cylinder is disposed within each opening. A conical block is disposed at the output end of the second cylinder. Several second sliding rods are evenly slidably connected to the outer side of the conical block. The other end of each second sliding rod is fixedly connected to the outer side of the bottom end of a clamping rod. A rotating shaft is disposed in the middle of the clamping rod. Both ends of the rotating shaft are provided with fixing plates.

[0007] As an improvement to the above technical solution, the fixing plate is symmetrically arranged on the outside of the chassis, and a number of sliding grooves are evenly opened on the outer top of the chassis. A spring is installed in the sliding groove, and a first sliding rod is provided at one end of the spring. The other end of the first sliding rod is provided on the outer top of the clamping rod.

[0008] As an improvement to the above technical solution, the bottom of the dispensing station is provided with an inner groove, a support base is provided in the inner groove, and a support column is provided on the top of the support base.

[0009] As an improvement to the above technical solution, a motor is installed inside the support base, and the output end of the motor is fixedly connected to a disassembly platform.

[0010] As an improvement to the above technical solution, a top plate is provided on the top of the support column, and a plurality of first cylinders are evenly arranged on the top of the top plate. A lifting plate is fixedly connected to the output end of the first cylinder, and an injection port is provided at the bottom of the lifting plate.

[0011] As an improvement to the above technical solution, a pressure sensor is provided at the top of the clamping rod.

[0012] As an improvement to the above technical solution, an injection bottle is provided on the top of the chassis.

[0013] The beneficial effects of this utility model are:

[0014] 1. By activating the second cylinder, the conical block at its output end moves. The movement of the conical block, due to its shape, moves the matching second slide rod. The movement of the second slide rod causes the clamping rod connected to it to rotate around a pivot. As the clamping rod rotates, it moves within a groove using the first slide rod for guidance. The rotation of the clamping rod clamps the injection bottle on top of the chassis. A pressure sensor at the top of the clamping rod detects whether the clamping rod is in contact with the injection bottle, preventing excessive movement of the conical block by the second cylinder and thus preventing damage to the injection bottle. This structure can accommodate injection bottles of various sizes, and the clamping rod secures the injection bottle, preventing it from tipping over during injection.

[0015] 2. The lifting plate at the output end of the first cylinder set in the top plate moves up and down. The injection port at the bottom of the lifting plate can fill the injection bottle clamped and fixed below through the external infusion equipment. The position of the injection port can be adjusted by moving it up and down to adapt to injection bottles of different sizes. When changing to different injection bottle models, only the position needs to be adjusted, which reduces production interruption time and reduces splashing of injection liquid and the generation of bubbles. Attached Figure Description

[0016] Figure 1 This is a schematic diagram of the structure of this utility model;

[0017] Figure 2 This is a partial sectional view of the disassembly stage in this utility model;

[0018] Figure 3 This is a partial sectional view of the chassis in this utility model;

[0019] Reference numerals in the attached drawings: 1. Dispensing platform; 2. Support column; 3. First cylinder; 4. Injection port; 5. Injection bottle; 6. Opening; 7. Lifting plate; 8. Motor; 9. Support base; 10. Second cylinder; 11. Conical block; 12. Clamping rod; 13. Pressure sensor; 14. Chassis; 15. First slide rod; 16. Slide groove; 17. Spring; 18. Second slide rod; 19. Rotating shaft; 20. Fixing plate; 21. Top plate; 22. Inner groove. Detailed Implementation

[0020] To make the objectives, technical solutions, and advantages of this utility model clearer, the following provides a more detailed description of the utility model. It should be understood that the specific embodiments described herein are merely illustrative and not intended to limit the scope of the utility model.

[0021] Please refer to Figures 1-3 A dispensing structure for neostigmine bromide injection includes a dispensing platform 1. The top of the dispensing platform 1 has several openings 6 evenly distributed. A second cylinder 10 is installed within each opening 6. A conical block 11 is installed at the output end of the second cylinder 10. Several second sliding rods 18 are evenly slidably connected to the outer side of the conical block 11. The other end of each second sliding rod 18 is fixedly connected to the outer side of the bottom end of a clamping rod 12. A rotating shaft 19 is installed in the middle of the clamping rod 12. Fixing plates 20 are installed at both ends of the rotating shaft 19. The fixing plates 20 are symmetrically arranged on the outer side of a base 14. Several sliding grooves 16 are evenly distributed on the outer side of the top end of the base 14. Springs 17 are installed within the sliding grooves 16. A first sliding rod 15 is installed at one end of each spring 17. The other end of the first sliding rod 15 is installed on the outer side of the top end of the clamping rod 12. An injection bottle 5 is installed on the top of the base 14.

[0022] Specifically, by activating the second cylinder 10, the conical block 11 at its output end is moved. When the conical block 11 moves, its shape drives the matching second slide rod 18 to move. The movement of the second slide rod 18 drives the clamping rod 12 connected to it to rotate around the pivot 19. The clamping rod 12 is set on the outside of the chassis 14 with the pivot 19 and the fixing plate 20. When the clamping rod 12 rotates, it moves in the slide groove 16 with the help of the first slide rod 15 to guide it. The spring 17 set at the other end of the first slide rod 15 plays a limiting role. The rotation of the clamping rod 12 clamps the injection bottle 5 on the top of the chassis 14. This structure can adapt to injection bottles 5 of various sizes, and the clamping rod 12 clamps and fixes the injection bottle 5 to prevent the injection bottle 5 from tipping over during injection.

[0023] Please refer to Figures 1-3The bottom of the dispensing table 1 has an inner groove 22, a support base 9 is provided in the inner groove 22, a support column 2 is provided on the top of the support base 9, a motor 8 is provided in the support base 9, and the output end of the motor 8 is fixedly connected to the dispensing table 1.

[0024] Specifically, the support column 2 is connected to the support base 9. The support column 2 is located in the middle of the dispensing platform 1 but is not connected. The motor 8 can drive the dispensing platform 1 to rotate, which facilitates the pouring.

[0025] Please refer to Figures 1-3 The top of the support column 2 is provided with a top plate 21, and a number of first cylinders 3 are evenly arranged on the top of the top plate 21. The output end of the first cylinder 3 is fixedly connected to a lifting plate 7, and the bottom of the lifting plate 7 is provided with an injection port 4.

[0026] Specifically, the first cylinder 3 installed in the top plate 21 drives the lifting plate 7 at its output end to move up and down. The injection port 4 at the bottom of the lifting plate 7 can fill the injection bottle 5 clamped and fixed below through an externally connected infusion device. By moving up and down to adjust the position of the injection port 4, it can adapt to injection bottles 5 of different sizes. When changing to different models of injection bottles 5, only the position needs to be adjusted, which reduces production interruption time and reduces splashing of injection liquid and the generation of bubbles.

[0027] Please refer to Figures 1-3 A pressure sensor 13 is provided on the top of the clamping rod 12.

[0028] Specifically, the pressure sensor 13 at the top of the clamping rod 12 detects whether the clamping rod 12 is in contact with the injection bottle 5, preventing the second cylinder 10 from excessively moving the conical block 11 and thus damaging the injection bottle 5.

[0029] The above embodiments are only used to illustrate the technical solution of this utility model, and are not intended to limit it.

Claims

1. A dispensing structure for neostigmine bromide injection, comprising a dispensing station (1), characterized in that: The top of the dispensing platform (1) is evenly provided with several openings (6), and a second cylinder (10) is provided in the opening (6). A conical block (11) is provided at the output end of the second cylinder (10). Several second slide rods (18) are evenly slidably connected to the outer side of the conical block (11). The other end of the second slide rod (18) is fixedly connected to the outer side of the bottom end of the clamping rod (12). A rotating shaft (19) is provided in the middle of the clamping rod (12), and a fixing plate (20) is provided at both ends of the rotating shaft (19).

2. The packaging structure for glycopyrronium bromide neostigmine injection according to claim 1, characterized in that: The fixing plate (20) is symmetrically arranged on the outside of the chassis (14). Several sliding grooves (16) are evenly opened on the outer side of the top of the chassis (14). A spring (17) is provided in the sliding groove (16). A first sliding rod (15) is provided at one end of the spring (17). The other end of the first sliding rod (15) is provided on the outer side of the top of the clamping rod (12).

3. The packaging structure for glycopyrronium bromide neostigmine injection according to claim 1, characterized in that: The bottom of the dispensing station (1) is provided with an inner groove (22), a support seat (9) is provided in the inner groove (22), and a support column (2) is provided on the top of the support seat (9).

4. The packaging structure for glycopyrronium bromide neostigmine injection according to claim 3, characterized in that: The support base (9) is equipped with a motor (8), and the output end of the motor (8) is fixedly connected to a dispensing platform (1).

5. The packaging structure for glycopyrronium bromide neostigmine injection according to claim 3, characterized in that: The top of the support column (2) is provided with a top plate (21), and a plurality of first cylinders (3) are evenly arranged on the top of the top plate (21). The output end of the first cylinder (3) is fixedly connected to a lifting plate (7), and the bottom of the lifting plate (7) is provided with an injection port (4).

6. The packaging structure for glycopyrronium bromide neostigmine injection according to claim 1, characterized in that: A pressure sensor (13) is provided on the top of the clamping rod (12).

7. The packaging structure for glycopyrronium bromide neostigmine injection according to claim 2, characterized in that: An injection bottle (5) is provided on the top of the chassis (14).

Images